Home > Insider Trading > Filing (0001179110-15-012282)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145460	Alere Inc.	ALR	In Vitro & In Vivo Diagnostic Substances (2835)	043565120

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571523	Sanjay Malkani	51 Sawyer Road, Suite 200 Waltham MA 02453	Global Pres., Toxicology	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-08-14	8,960	$44.64	15,182	No	4	M	Direct
Common Stock	Acquisiton	2015-08-14	22,500	$26.06	37,682	No	4	M	Direct
Common Stock	Disposition	2015-08-14	31,460	$54.60	6,222	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2015-08-14	8,960	$0.00	8,960	$44.64
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2015-08-14	22,500	$0.00	22,500	$26.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,040		2018-02-12	No	4	M	Direct
7,500		2021-10-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	565	Indirect	See Footnote

Footnotes

Represents same day exercise and sale of stock options.
Option vested in four equal annual installments on 2/12/09, 2/12/10, 2/12/11 and 2/12/12.
Option will vest in four equal annual installments on 10/31/12, 10/31/13, 10/31/14 and 10/31/15.
The derivative security does not have a price.
The price reported is a weighted average price. These shares were sold in approximately 310 separate transactions at prices ranging from $54.45 to $54.88, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was affected.
These securities are owned by the reporting person's spouse.
The reporting person hereby disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16.